InvestorsHub Logo
Followers 17
Posts 544
Boards Moderated 0
Alias Born 02/06/2010

Re: None

Saturday, 11/28/2015 10:26:55 PM

Saturday, November 28, 2015 10:26:55 PM

Post# of 462472
Where do small biotech companies go to get financing for high priced trials? Perhaps Missling could approach the pawn shops and serve up his house or maybe trade in his house for cash on a one shot chance for black jack at a Las Vegas casino or put all the cash on a mega million lottery ticket to finance the trials How do you bring a promising drug to market when your resources are limited. You take a chance, incur some risk and push forward. Why did they choose Lincoln Financial? What choices does Missling have?

Once a drug makes it to the phase 2 trials, the probability of success is 30%, phase 3 trials, the probability of success goes to 60%, FDA trial 90%. ( Source: Investopedia). Small drug companies command greater royalties as the drug moves successfully through the trials. To maximize the negotiated royalty received from its BP partner, Missling has to get the drug to the phase 3 trials. When approved for phase 3 trials, the stock will move up like KBIO did this past week. At some point, AVXL will have to engage a partner, not only for financial reasons but to use BP's massive marketing, sales and distribution channels. Hold onto your shares and your hats, this stock will likely quadruple from its current share price




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News